Publication details

Studie PARADIGM-HF možná změní léčbu srdečního selhání

Title in English PARADIGM-HF study could change the treatment of heart failure
Authors

ŠPINAR Jindřich ŠPINAROVÁ Lenka VÍTOVEC Jiří

Year of publication 2014
Type Article in Periodical
Magazine / Source Hypertenze & kardiovaskulární prevence
MU Faculty or unit

Faculty of Medicine

Citation
Field Cardiovascular diseases incl. cardiosurgery
Keywords heart failure; enalapril; neprilyzin
Description The PARADIGM-HF study compares the renin angiotenzin inhibitor receptor and neprilyzin ihibitor LCZ696 with enalapril in patients with heart failure and decreased ejection fraction. The study confirms, that the combination treatment can further improve the prognosis.

You are running an old browser version. We recommend updating your browser to its latest version.

More info